Inventor · disambiguated record
Tianci Luo
Also filed as: LUO TIANCI
24 granted patents·5 pending applications·127 citations·filing 2000–2024
95Inventor score
Files withNOVARTIS AG11WELLSTAT IMMUNOTHERAPEUTICS LLC6PHARMA CINQ LLC3WELLSTAT OPHTHALMICS CORP3ADVANCED VISION THERAPIES INC1
Top patents by PatentIndex Score
29 records- 0195US7202079B2Bovine immunodeficiency virus (BIV) based vectorsNOVARTIS AG·Filed 2005·Granted Apr 10, 2007·22 cites·44 claims
- 0293US6864085B2Bovine immunodeficiency virus (BIV) based vectorsNOVARTIS AG·Filed 2000·Granted Mar 8, 2005·24 cites·28 claims
- 0392US7442551B2Lentiviral packaging constructsNOVARTIS AG·Filed 2006·Granted Oct 28, 2008·16 cites·17 claims
- 0488US7785877B2Bovine immunodeficiency virus (BIV) based vectorsNOVARTIS AG·Filed 2005·Granted Aug 31, 2010·3 cites·26 claims
- 0588US7198793B2Bovine immunodeficiency virus (BIV) based vectorsNOVARTIS AG·Filed 2005·Granted Apr 3, 2007·6 cites·21 claims
- 0688US7125712B2Bovine immunodeficiency virus (BIV) based vectorsNOVARTIS AG·Filed 2005·Granted Oct 24, 2006·5 cites·56 claims
- 0788US7070993B2Lentiviral packaging constructsNOVARTIS AG·Filed 2002·Granted Jul 4, 2006·16 cites·24 claims
- 0887US7662621B2Bovine immunodeficiency virus (BIV) based vectorsNOVARTIS AG·Filed 2006·Granted Feb 16, 2010·4 cites·49 claims
- 0986US9265813B2Vectors encoding rod-derived cone viability factorWELLSTAT OPHTHALMICS CORP·Filed 2012·Granted Feb 23, 2016·9 cites·16 claims
- 1085US7153512B2Bovine immunodeficiency virus (BIV) based vectorsNOVARTIS AG·Filed 2005·Granted Dec 26, 2006·3 cites·17 claims
- 1183US7700342B2Lentiviral packaging constructsNOVARTIS AG·Filed 2006·Granted Apr 20, 2010·3 cites·8 claims
- 1282US8236558B2Bovine immunodeficiency virus (BIV) based vectorsLUO TIANCI·Filed 2010·Granted Aug 7, 2012·3 cites·16 claims
- 1382US2024374683A1Fusion protein between short form rod-derived cone viability factor and a hydrophilic peptidePHARMA CINQ LLC·Filed 2024·Application pending·0 cites
- 1481US10040835B2Vectors encoding rod-derived cone viability factorWELLSTAT OPHTHALMICS CORP·Filed 2015·Granted Aug 7, 2018·3 cites·26 claims
- 1579US10415026B2Complement factor B analogs and their usesWELLSTAT IMMUNOTHERAPEUTICS LLC·Filed 2016·Granted Sep 17, 2019·2 cites·18 claims
- 1678US9533028B2Complement factor B analogs and their usesWELLSTAT IMMUNOTHERAPEUTICS LLC·Filed 2015·Granted Jan 3, 2017·2 cites·17 claims
- 1776US9228003B2Complement factor B analogs and their usesCHEN CHANGHUNG·Filed 2012·Granted Jan 5, 2016·4 cites·15 claims
- 1872US11001822B2Complement factor B analogs and their usesWELLSTAT IMMUNOTHERAPEUTICS LLC·Filed 2020·Granted May 11, 2021·0 cites·23 claims
- 1972US10689637B2Complement factor B analogs and their usesWELLSTAT IMMUNOTHERAPEUTICS LLC·Filed 2019·Granted Jun 23, 2020·0 cites·16 claims
- 2071US12076367B2Fusion protein between short form rod-derived cone viability factor and a hydrophilic peptidePHARMA CINQ LLC·Filed 2021·Granted Sep 3, 2024·0 cites·10 claims
- 2171US8183356B2Lentiviral packaging constructsKALEKO MICHAEL·Filed 2007·Granted May 22, 2012·1 cites·24 claims
- 2269US2024342313A1Vector encoding rod-derived cone viability factor and human igk signal sequencePHARMA CINQ LLC·Filed 2024·Application pending·0 cites
- 2365US10946063B2Fusion protein between short form rod-derived cone viability factor and a hydrophilic peptideWELLSTAT OPHTHALMICS CORP·Filed 2017·Granted Mar 16, 2021·0 cites·7 claims
- 2465US8338384B2Method for treating ocular neovascularizationBRAZZELL ROMULUS KIMBRO·Filed 2010·Granted Dec 25, 2012·1 cites·27 claims
- 2559US2022169701A1Enveloped Virus Resistant to Complement Inactivation for the Treatment of CancerWELLSTAT IMMUNOTHERAPEUTICS LLC·Filed 2022·Application pending·0 cites
- 2656US9238057B2Method for treating ocular neovascularizationNOVARTIS AG·Filed 2012·Granted Jan 19, 2016·0 cites·22 claims
- 2754US11274141B2Enveloped virus resistant to complement inactivation for the treatment of cancerWELLSTAT IMMUNOTHERAPEUTICS LLC·Filed 2018·Granted Mar 15, 2022·0 cites·15 claims
- 2849US2010120665A1Treatment of diseases characterized by inflammationADVANCED VISION THERAPIES INC·Filed 2008·Application pending·0 cites
- 2946US2005191747A1Recombinant bovine immunodeficiency virus based gene transfer systemFiled 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tianci Luo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →